<DOC>
	<DOCNO>NCT00195819</DOCNO>
	<brief_summary>The purpose study assess safety clinical efficacy adalimumab subject active ankylose spondylitis</brief_summary>
	<brief_title>Safety Efficacy Adalimumab Patients With Active Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject age 18 older relatively good health ( Investigator discretion ) recent stable medical history . Subject meet definition AS base Modified New York Criteria . Subject inadequate response intolerance one NSAIDs define Investigator Subject previously receive antiTNF therapy . Subject consider investigator , reason , unsuitable candidate study Female subject pregnant breastfeeding consider become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>ankylose spondylitis</keyword>
	<keyword>adalimumab</keyword>
</DOC>